Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Department of General Surgery, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Dis Markers. 2020 May 31;2020:8460883. doi: 10.1155/2020/8460883. eCollection 2020.
Early detection is crucial for the prognosis of patients with autoimmune liver disease (AILD). Due to the relatively low incidence, developing screening tools for AILD remain a challenge.
To analyze clinical characteristics of AILD patients at initial presentation and identify clinical markers, which could be useful for disease screening and early detection.
We performed observational retrospective study and analyzed 581 AILD patients who were hospitalized in the gastroenterology department and 1000 healthy controls who were collected from health management center. Baseline characteristics at initial presentation were used to build regression models. The model was validated on an independent cohort of 56 patients with AILD and 100 patients with other liver disorders.
Asymptomatic AILD individuals identified by the health check-up are increased yearly (from 31.6% to 68.0%, < 0.001). The cirrhotic rates at an initial presentation are decreased in the past 18 years (from 52.6% to 20.0%, < 0.001). Eight indicators, which are common in the health check-up, are independent risk factors of AILD. Among them, abdominal lymph node enlargement (LN) positive is the most significant different (OR 8.85, 95% CI 2.73-28.69, < 0.001). The combination of these indicators shows high predictive power (AUC = 0.98, sensitivity 89.0% and specificity 96.4%) for disease screening. Except two liver or cholangetic injury makers, the combination of AGE, GENDER, GLB, LN, concomitant extrahepatic autoimmune diseases, and familial history also shows a high predictive power for AILD in other liver disorders ( = 0.91).
Screening for AILD with described parameters can detect AILD in routine health check-up early, effectively and economically. Eight variables in routine health check-up are associated with AILD and the combination of them shows good ability of identifying high-risk individuals.
早期发现对于自身免疫性肝病 (AILD) 患者的预后至关重要。由于发病率相对较低,因此开发 AILD 的筛查工具仍然是一个挑战。
分析 AILD 患者初次就诊时的临床特征,并确定有助于疾病筛查和早期发现的临床标志物。
我们进行了一项观察性回顾性研究,分析了在消化内科住院的 581 名 AILD 患者和从健康管理中心收集的 1000 名健康对照者。使用初次就诊时的基线特征建立回归模型。该模型在另外 56 名 AILD 患者和 100 名其他肝脏疾病患者的独立队列中进行了验证。
通过健康检查发现的无症状 AILD 个体逐年增加(从 31.6%增加到 68.0%,<0.001)。过去 18 年来,初次就诊时的肝硬化率降低(从 52.6%降至 20.0%,<0.001)。八项在健康检查中常见的指标是 AILD 的独立危险因素。其中,腹部淋巴结肿大(LN)阳性是最显著的差异(OR 8.85,95%CI 2.73-28.69,<0.001)。这些指标的组合具有较高的疾病筛查预测能力(AUC=0.98,敏感性 89.0%,特异性 96.4%)。除了两种肝或胆管损伤标志物外,AGE、GENDER、GLB、LN、同时存在的肝外自身免疫性疾病和家族史的组合对其他肝脏疾病中的 AILD 也具有较高的预测能力(=0.91)。
使用描述的参数对 AILD 进行筛查可以在常规健康检查中早期、有效且经济地发现 AILD。常规健康检查中的八个变量与 AILD 相关,它们的组合具有较好的识别高危个体的能力。